Compare iShares Core US Aggregate Bond ETF (AGG) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
iShares Core US Aggregate Bond ETF vs Neurocrine Biosciences Inc — how do they compare? iShares Core US Aggregate Bond ETF trades at $98.05, while Neurocrine Biosciences Inc trades at $179.5 (market cap $17.84B). The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, iShares Core US Aggregate Bond ETF nearer its low. Which is the better fit depends on your goals.
| AGG | NBIX | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $101.40 | $177.49 |
52-Week Low | $97.63 | $123.10 |
Market Cap | — | $17.84B |
Enterprise Value | — | $16.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core US Aggregate Bond ETF
AGG tracks the Bloomberg U.S. Aggregate Bond Index, providing broad exposure to the total U.S. investment-grade bond market. It serves as a core portfolio building block by diversifying across Treasuries, government-related bonds, corporate debt, and mortgage-backed securities.
Read more on AGG →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
